Publication Cover
Hemoglobin
international journal for hemoglobin research
Volume 36, 2012 - Issue 3
181
Views
3
CrossRef citations to date
0
Altmetric
Original Article

Molecular and Cellular Characterization of a New α-Thalassemia Mutation (HBA2:c.94A>C) Generating an Alternative Splice Site and a Premature Stop Codon

, , , , , , , , & show all
Pages 244-252 | Received 12 Dec 2011, Accepted 27 Jan 2012, Published online: 23 Apr 2012

REFERENCES

  • Rund D, Rachmilewitz E. β-Thalassemia. N Engl J Med. 2005;353(11):1135–1146.
  • Harteveld CL, Higgs DR. α-Thalassemia. Orphanet J Rare Dis. 2010;5(1):13–23.
  • Strachan T, Read AP. Human Molecular Genetics 3, 3rd ed. New York: Garland Science, 2004.
  • Weatherall DJ. Beginnings: the molecular pathology of hemoglobin. In: Provan D, Gribben J, Eds. Molecular Hematology, 3rd ed. Chichester: Wiley-Blackwell. 2010:1–18.
  • Patrinos GP, Giardine B, Riemer C, et al. Improvements in the HbVar database of human hemoglobin variants and thalassemia mutations for population and sequence variation studies. Nucleic Acids Res. 2004;32(Database issue):D537-D541 (http://globin.cse.psu.edu).
  • Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res. 1988;16(3):1215.
  • Tan AS, Quah TC, Low PS, Chong SS. A rapid and reliable 7-deletion multiplex polymerase chain reaction assay for α-thalassemia. Blood. 2001;98(1):250–251.
  • Dodé C, Rochette J, Krishnamoorthy R. Locus assignment of human α globin mutations by selective amplification and direct sequencing. Br J Haematol. 1990;76(2):275–281.
  • Harteveld CL, Versteegh FGA, Kok PJMJ, van Rooijen-Nijdam IH, van Delft P, Giordano PC. Hb Bleuland [α108(G15)Thr→Asn, ACC→AAC (α2)]: a new abnormal hemoglobin associated with a mild α-thalassemia phenotype. Hemoglobin. 2006;30(3):349–354.
  • Hebsgaard SM, Korning PG, Tolstrup N, Engelbrecht J, Rouze P, Brunak S. Splice site prediction in Arabidopsis thaliana pre-mRNA by combining local and global sequence information. Nucleic Acids Res. 1996;24(17):3439–3452.
  • Gasteiger E, Gattiker A, Hoogland C, Ivanyi I, Appel RD, Bairoch A. ExPASy: the proteomics server for in-depth protein knowledge and analysis. Nucleic Acids Res. 2003;31(13):3784–3788.
  • Qadah T, Finlayson J, Ghassemifar R. In vitro characterization of the α-thalassemia point mutation HBA2:c.95+1G>A [IVS-I-1(G>A)]. Hemoglobin. 2012;36(1):38–46.
  • Ermakova EO, Nurtdinov RN, Gelfand MS. Overlapping alternative donor splice sites in the human genome. J Bioinform Comput Biol. 2007;5(5):991–1004.
  • Baralle D, Baralle M. Splicing in action: assessing disease causing sequence changes. J Med Genet. 2005;42(10):737–748.
  • Orkin SH, Goff SC, Hechtman RL. Mutation in an intervening sequence splice junction in man. Proc Natl Acad Sci USA. 1981;78(8):5041–5045.
  • Harteveld CL, Beijer C, van Delft P, Zanardini R, Bernini LF, Giordano PC. α-Thalassaemia as a result of a novel splice donor site mutation of the α1-globin gene. Br J Haematol. 2000;110(3):694–698.
  • Waye JS, Eng B, Dutly F, Frischknecht H. α-Thalassemia caused by two novel splice mutations of the α2-globin gene: IVS-I-1 (G>A and G>T). Hemoglobin. 2009;33(6):519–522.
  • Khajavi M, Inoue K, Lupski JR. Nonsense-mediated mRNA decay modulates clinical outcome of genetic disease. Eur J Hum Genet. 2006;14(10):1074–1081.
  • Maquat LE. Nonsense-mediated mRNA decay: splicing, translation and mRNP dynamics. Nat Rev Molec Cell Biol. 2004;5(2):89–99.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.